Recent News

Start-up with UNC ties secures $2.9M to develop blood test for cancer

Start-up with UNC ties secures $2.9M to develop blood test for cancer

A start-up company co-founded by UNC Lineberger researcher Andrew Wang, MD, has raised $2.9 million to commercialize a test designed to capture cancer cells circulating in the blood.

Start-up with UNC ties secures $2.9M to develop blood test for cancer - Read More…

Inside the world of cell signaling: a G-protein breakthrough

Inside the world of cell signaling: a G-protein breakthrough

Scientists led by UNC Lineberger member John Sondek, PhD, created a new biochemical tool to block specific types of downstream G-protein signaling, opening new avenues of research and potential drug design and discovery.

Inside the world of cell signaling: a G-protein breakthrough - Read More…

In blood of patients treated for other cancers, researchers find genetic precursors of leukemia

In blood of patients treated for other cancers, researchers find genetic precursors of leukemia

In a study presented at the American Society of Hematology Annual Meeting in San Diego, Catherine C. Coombs, MD, MS, and colleagues reported that nearly a quarter of patients heavily treated for other cancers had mutations in their white blood cells, and that the majority of those mutations were leukemia-linked.

In blood of patients treated for other cancers, researchers find genetic precursors of leukemia - Read More…

UNC, Duke researchers unite around mission of preventing virus-induced cancers

UNC, Duke researchers unite around mission of preventing virus-induced cancers

Researchers and clinicians attended the 2016 UNC-Duke Viral Oncology & AIDS Malignancy Symposium on Dec. 14 to hear presentations and share their perspectives on the latest efforts to prevent and treat cancers linked to infectious agents.

UNC, Duke researchers unite around mission of preventing virus-induced cancers - Read More…